Evidence map›Paper›PMID 17784789›Full record

ArticlePLoS genetics2007

The complete genome sequence of Yersinia pseudotuberculosis IP31758, the causative agent of Far East scarlet-like fever.

Mark Eppinger, M J Rosovitz, Wolfgang Florian Fricke, David A Rasko, Galina Kokorina, Corinne Fayolle, Luther E Lindler, Elisabeth Carniel, Jacques Ravel

Open access · goldAbstract readComparative Study
In one paragraph

Article in PLoS genetics, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 116 citations in OpenAlex.

  1. Article
  2. Article
  3. Complete genome sequence ofMicrobiology resource announcements · 2023
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Extraintestinal Manifestation ofPathogens (Basel, Switzerland) · 2021
    Article
  10. Early evolutionary loss of the lipid A modifying enzyme PagP resulting in innate immune evasion inProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  11. Review
  12. Article
  13. X-ray crystal structures of the type IVb secretion system DotB ATPases.Protein science : a publication of the Protein Society · 2018
    Article
  14. Review
  15. Article
  16. Structure of the Y. pseudotuberculosis adhesin InvasinE.Protein science : a publication of the Protein Society · 2017
    Article
  17. Article
  18. Reannotation of Yersinia pestis Strain 91001 Based on Omics Data.The American journal of tropical medicine and hygiene · 2016
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Mark EppingerJ. Craig Venter Institute/The Institute for Genomic Research, Microbial Genomics, Rockville, Maryland, United States of America.
M J Rosovitz
Wolfgang Florian Fricke
David A Rasko
Galina Kokorina
Corinne Fayolle
Luther E Lindler
Elisabeth Carniel
Jacques Ravel
J. Craig Venter Institute · USInstitut Pasteur · FRUnited States Department of Defense · US

Funding

NIAID NIH HHS N01 AI030071
6 · The paper itself

Abstract

The first reported Far East scarlet-like fever (FESLF) epidemic swept the Pacific coastal region of Russia in the late 1950s. Symptoms of the severe infection included erythematous skin rash and desquamation, exanthema, hyperhemic tongue, and a toxic shock syndrome. The term FESLF was coined for the infection because it shares clinical presentations with scarlet fever caused by group A streptococci. The causative agent was later identified as Yersinia pseudotuberculosis, although the range of morbidities was vastly different from classical pseudotuberculosis symptoms. To understand the origin and emergence of the peculiar clinical features of FESLF, we have sequenced the genome of the FESLF-causing strain Y. pseudotuberculosis IP31758 and compared it with that of another Y. pseudotuberculosis strain, IP32953, which causes classical gastrointestinal symptoms. The unique gene pool of Y pseudotuberculosis IP31758 accounts for more than 260 strain-specific genes and introduces individual physiological capabilities and virulence determinants, with a significant proportion horizontally acquired that likely originated from Enterobacteriaceae and other soil-dwelling bacteria that persist in the same ecological niche. The mobile genome pool includes two novel plasmids phylogenetically unrelated to all currently reported Yersinia plasmids. An icm/dot type IVB secretion system, shared only with the intracellular persisting pathogens of the order Legionellales, was found on the larger plasmid and could contribute to scarlatinoid fever symptoms in patients due to the introduction of immunomodulatory and immunosuppressive capabilities. We determined the common and unique traits resulting from genome evolution and speciation within the genus Yersinia and drew a more accurate species border between Y. pseudotuberculosis and Y. pestis. In contrast to the lack of genetic diversity observed in the evolutionary young descending Y. pestis lineage, the population genetics of Y. pseudotuberculosis is more heterogenous. Both Y. pseudotuberculosis strains IP31758 and the previously sequenced Y. pseudotuberculosis strain IP32953 have evolved by the acquisition of specific plasmids and by the horizontal acquisition and incorporation of different genetic information into the chromosome, which all together or independently seems to potentially impact the phenotypic adaptation of these two strains.

Indexed as

Genome, FungalBacteriophagesGenes, FungalGene SilencingGenomic IslandsHumansMolecular Sequence DataMycotoxinsPlasmidsScarlet FeverSpecies SpecificitySuperantigensVirulence FactorsYersinia pestisYersinia pseudotuberculosisYersinia pseudotuberculosis InfectionsMycotoxinsSuperantigensVirulence Factors

Identifiers

PMID17784789
PMCPMC1959361
OpenAlexW2028396929

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.